Trial Profile
Study to evaluate the safety and efficacy of tocilizumab, in patients with AA amyloidosis secondary to familial mediterranean fever
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Feb 2016
Price :
$35
*
At a glance
- Drugs Tocilizumab (Primary)
- Indications Familial Mediterranean fever
- Focus Therapeutic Use
- 27 Aug 2015 New trial record